Issued Patents All Time
Showing 1–18 of 18 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10463624 | Controlled release formulations | Andrew Darke | 2019-11-05 |
| 10258616 | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Whitehouse +1 more | 2019-04-16 |
| 10039719 | Methods of treating attention deficit hyperactivity disorder | Andrew Darke | 2018-08-07 |
| 10022330 | Methods of preparing oral controlled release formulations | Andrew Darke | 2018-07-17 |
| 9949931 | Methods of treating attention deficit hyperactivity disorder | Andrew Darke | 2018-04-24 |
| 9814710 | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Whitehouse +1 more | 2017-11-14 |
| 9801823 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2017-10-31 |
| 9700508 | Pharmaceutical compositions comprising hydromorphone and naloxone | Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Whitehouse +1 more | 2017-07-11 |
| 9066869 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2015-06-30 |
| 8580310 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2013-11-12 |
| 7438930 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2008-10-21 |
| 7247318 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2007-07-24 |
| 7083808 | Controlled/modified release oral methylphenidate formulations | Paul Goldenheim, Richard Sackler, Andrew Darke, Benjamin Oshlaci | 2006-08-01 |
| 6673367 | Controlled/modified release oral methylphenidate formulations | Paul Goldenheim, Richard Sackler, Andrew Darke, Benjamin Oshlack | 2004-01-06 |
| 6419960 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Andrew Darke | 2002-07-16 |
| 5811126 | Controlled release matrix for pharmaceuticals | — | 1998-09-22 |
| 5508043 | Controlled release matrix for pharmaceuticals | — | 1996-04-16 |
| 5215758 | Controlled release matrix suppository for pharmaceuticals | — | 1993-06-01 |